Cortellini, A., Filetti, M., Citarella, F., Giusti, R., Russano, M., Grossi, F., . . . Pinato, D. (2021). 10P Family history of cancer correlates with improved outcome from immunotherapy in NSCLC independent of somatic DNA damage response gene status. Annals of Oncology, 32, S1378. https://doi.org/10.1016/j.annonc.2021.10.026
Chicago Style (17th ed.) CitationCortellini, A., et al. "10P Family History of Cancer Correlates with Improved Outcome from Immunotherapy in NSCLC Independent of Somatic DNA Damage Response Gene Status." Annals of Oncology 32 (2021): S1378. https://doi.org/10.1016/j.annonc.2021.10.026.
MLA (9th ed.) CitationCortellini, A., et al. "10P Family History of Cancer Correlates with Improved Outcome from Immunotherapy in NSCLC Independent of Somatic DNA Damage Response Gene Status." Annals of Oncology, vol. 32, 2021, p. S1378, https://doi.org/10.1016/j.annonc.2021.10.026.